The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling. 2012

Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
St. Vincent's Institute of Medical Research, Fitzroy, Vic., Australia.

Granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 are members of a discrete family of cytokines that regulates the growth, differentiation, migration and effector function activities of many hematopoietic cells and immunocytes. These cytokines are involved in normal responses to infectious agents, bridging innate and adaptive immunity. However, in certain cases, the overexpression of these cytokines or their receptors can lead to excessive or aberrant initiation of signaling resulting in pathological conditions, with chronic inflammatory diseases and myeloid leukemias the most notable examples. Recent crystal structures of the GM-CSF receptor ternary complex and the IL-5 binary complex have revealed new paradigms of cytokine receptor activation. Together with a wealth of associated structure-function studies, they have significantly enhanced our understanding of how these receptors recognize cytokines and initiate signals across cell membranes. Importantly, these structures provide opportunities for structure-based approaches for the discovery of novel and disease-specific therapeutics. In addition, recent biochemical evidence has suggested that the GM-CSF/IL-3/IL-5 receptor family is capable of interacting productively with other membrane proteins at the cell surface. Such interactions may afford additional or unique biological activities and might be harnessed for selective modulation of the function of these receptors in disease.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007377 Interleukin-3 A multilineage cell growth factor secreted by LYMPHOCYTES; EPITHELIAL CELLS; and ASTROCYTES which stimulates clonal proliferation and differentiation of various types of blood and tissue cells. Burst-Promoting Factor, Erythrocyte,Colony-Stimulating Factor 2 Alpha,Colony-Stimulating Factor, Mast-Cell,Colony-Stimulating Factor, Multipotential,Erythrocyte Burst-Promoting Factor,IL-3,Mast-Cell Colony-Stimulating Factor,Multipotential Colony-Stimulating Factor,P-Cell Stimulating Factor,Eosinophil-Mast Cell Growth-Factor,Hematopoietin-2,Burst Promoting Factor, Erythrocyte,Colony Stimulating Factor, Mast Cell,Colony Stimulating Factor, Multipotential,Eosinophil Mast Cell Growth Factor,Erythrocyte Burst Promoting Factor,Hematopoietin 2,Interleukin 3,Multipotential Colony Stimulating Factor,P Cell Stimulating Factor
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015848 Interleukin-5 A cytokine that promotes differentiation and activation of EOSINOPHILS. It also triggers activated B-LYMPHOCYTES to differentiate into IMMUNOGLOBULIN-secreting cells. B-Cell Growth Factor-II,Eosinophil Differentiation Factor,IL-5,T-Cell Replacing Factor,BCGF-II,Differentiation Factor, Eosinophil,IL5,T-Cell-Replacing Factor,B Cell Growth Factor II,Interleukin 5,Replacing Factor, T-Cell,T Cell Replacing Factor

Related Publications

Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
March 2001, Cytokine & growth factor reviews,
Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
October 2003, The Journal of allergy and clinical immunology,
Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
April 1999, Annals of the New York Academy of Sciences,
Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
October 1998, Cellular signalling,
Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
January 2006, Vitamins and hormones,
Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
April 2019, Immunity,
Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
December 2016, Developmental and comparative immunology,
Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
January 1998, Stem cells (Dayton, Ohio),
Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
October 1997, American journal of hematology,
Sophie E Broughton, and Urmi Dhagat, and Timothy R Hercus, and Tracy L Nero, and Michele A Grimbaldeston, and Claudine S Bonder, and Angel F Lopez, and Michael W Parker
October 1995, Blood,
Copied contents to your clipboard!